Further, cognitive stimulation given at a pre-plaque and pre-symptomatic phase protected from cognitive decline in accordance with an increase of PAI-1, decreased activity of tPA, and enhanced production of mBDNF in AD model mice. Here, SERPINE1 is linked to Alzheimer disease.